QRG Capital Management Inc. reduced its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 38.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 10,739 shares of the semiconductor company's stock after selling 6,745 shares during the period. QRG Capital Management Inc.'s holdings in Synopsys were worth $4,790,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. AGH Wealth Advisors LLC raised its position in Synopsys by 4.4% during the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company's stock worth $226,000 after buying an additional 24 shares during the last quarter. MCF Advisors LLC boosted its holdings in shares of Synopsys by 17.8% in the fourth quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company's stock valued at $81,000 after acquiring an additional 26 shares in the last quarter. Sumitomo Life Insurance Co. boosted its holdings in shares of Synopsys by 0.4% in the fourth quarter. Sumitomo Life Insurance Co. now owns 6,742 shares of the semiconductor company's stock valued at $3,167,000 after acquiring an additional 27 shares in the last quarter. Elevation Wealth Partners LLC increased its stake in shares of Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after acquiring an additional 27 shares during the period. Finally, Bar Harbor Wealth Management increased its stake in shares of Synopsys by 0.7% during the first quarter. Bar Harbor Wealth Management now owns 4,181 shares of the semiconductor company's stock worth $1,658,000 after acquiring an additional 31 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities research analysts recently commented on the stock. Needham & Company LLC restated a "buy" rating and issued a $580.00 price objective on shares of Synopsys in a research report on Thursday, August 27th. BNP Paribas Exane raised Synopsys from an "underperform" rating to a "neutral" rating and set a $420.00 target price for the company in a research note on Thursday. Weiss Ratings cut Synopsys from a "hold (c)" rating to a "hold (c-)" rating in a report on Friday, September 11th. UBS Group set a $570.00 price target on Synopsys in a research note on Thursday, August 27th. Finally, Zacks Research lowered Synopsys from a "strong-buy" rating to a "hold" rating in a report on Friday, August 21st. Fifteen equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $574.61.
Read Our Latest Report on SNPS
Synopsys Trading Up 0.2%
SNPS stock opened at $425.76 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The company has a market cap of $81.59 billion, a price-to-earnings ratio of 75.22, a PEG ratio of 2.33 and a beta of 1.23. The business has a fifty day simple moving average of $400.90 and a 200-day simple moving average of $435.61. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The firm's revenue was up 42.4% on a year-over-year basis. During the same period in the prior year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities research analysts expect that Synopsys, Inc. will post 10.97 EPS for the current year.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 14,604 shares of the firm's stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total value of $5,474,747.52. Following the transaction, the chief executive officer owned 76,865 shares in the company, valued at approximately $28,815,151.20. This trade represents a 15.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the completion of the sale, the insider directly owned 120,443 shares of the company's stock, valued at $50,518,611.92. The trade was a 16.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 89,245 shares of company stock valued at $37,992,919. Corporate insiders own 0.56% of the company's stock.
Synopsys News Summary
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: HSBC upgraded Synopsys to Buy and set a $700 price target, implying substantial upside from the recent trading level. The bank expects AI-related demand in electronic design automation and sees roughly 28% earnings growth through 2028, improving the stock’s risk-reward profile. Synopsys Stock Climbs as HSBC Upgrades Software Giant on AI Growth Tailwinds
- Positive Sentiment: Synopsys and Taiwan Semiconductor are collaborating to accelerate AI-system innovation. The partnership supports Synopsys’ positioning in advanced chip-design software and could reinforce long-term demand from AI infrastructure investment. Synopsys, Taiwan Semiconductor Collaborate to Accelerate AI Systems Innovation
- Positive Sentiment: BNP Paribas Exane raised its rating on SNPS from Underperform to Neutral, citing a potentially positive investor-day catalyst. The upgrade removes a bearish call, although its $420 target remains below the recent share price. Synopsys Shares Rise After BNP Paribas Upgrade
- Neutral Sentiment: Analysts broadly maintain a Moderate Buy consensus, while Synopsys remains a sales-growth candidate with strong industry exposure. However, its elevated valuation and position below the 200-day moving average make further gains dependent on stronger execution and guidance.
- Negative Sentiment: Investor attention remains focused on Synopsys’ performance since its last earnings report, with the stock down about 8.6% over that period despite revenue growth of 42.4% and an earnings beat. This suggests expectations and valuation, rather than current operating momentum alone, are weighing on sentiment. Why Is Synopsys Down Since Last Earnings Report?
- Negative Sentiment: A Motley Fool analysis cautioned that Synopsys’ non-GAAP earnings may look stronger than underlying results after adjustments. That accounting-quality concern could limit the market’s willingness to assign a premium multiple, particularly with the stock’s high price-to-earnings ratio. Why Synopsys Stock Popped, Then Dropped
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.
The company's EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.
Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.
Featured Stories
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.